Health
WASHINGTON — The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands more patients with the inherited disease.
Nobel Prize laureate Dr. Stanley Prusiner, who discovered a revolutionary new class of proteins that cause devastating brain diseases in both animals and humans, has become chair of the scientific advisory board of the Cleveland Clinic Lou Ruvo Center for Brain Health.
Dr. Dipak Desai, at the center of the hepatitis C outbreak, is faking his physical disabilities to obstruct the criminal case against him, a prosecutor argued Tuesday.
Patty Peterson considers herself someone who has “a pretty high pain threshold.” Yet for most of her life, Peterson, 54, went to the dentist only as a last resort. “I’d wait until something hurt, and then I’d go,” she says.
So different, yet so much the same. Sally Towey, an 81-year-old Las Vegan, was talking about the ordeals of Gabrielle Dee “Gabby” Giffords and her late daughter, Kim Sullivan.
WASHINGTON — Patients with hard-to-treat kidney cancer that has spread to other parts of the body gained a new drug option Friday after federal regulators approved a twice-a-day pill from Pfizer for the disease.